Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11964971 Methods and compositions for modulating splicing

Patent 11964971 was granted and assigned to Skyhawk Therapeutics on April, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 24 Apr, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 24 Apr, 2024
Edits made to:
Infobox (+82 properties)
Article (+328 characters)
‌

 US Patent 11964971 Methods and compositions for modulating splicing

Article

Patent abstract

Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, pharmaceutical compositions comprising the same, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Skyhawk Therapeutics
Skyhawk Therapeutics
0
Current Assignee
Skyhawk Therapeutics
Skyhawk Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
119649710
Patent Inventor Names
Brian Lucas0
Jun Feng0
Michael Luzzio0
Tiansheng Wang0
Date of Patent
April 23, 2024
0
Patent Application Number
173881000
Date Filed
July 29, 2021
0
Patent Citations
‌
US Patent 11129829 Methods for modulating splicing
0
‌
US Patent 7135484 Azabicyclic compounds are central nervous system active agents
0
‌
US Patent 7160876 Fused bicycloheterocycle substituted quinuclidine derivatives
0
‌
US Patent 7220741 1,4-diazabicycloalkane derivatives, their preparation and use
0
‌
US Patent 7309487 Methods and compositions for detecting and treating retinal diseases
0
‌
US Patent 7309699 3-Quinuclidinyl amino-substituted biaryl derivatives
0
‌
US Patent 7399765 Substituted diazabicycloalkane derivatives
0
‌
US Patent 7528132 Kinase inhibitors
0
‌
US Patent 7655657 Fused bicycloheterocycle substituted quinuclidine derivatives
0
‌
US Patent 7674794 Fused bicycloheterocycle substituted quinuclidine derivatives
0
‌
US Patent 7834178 Triazine 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
0
‌
US Patent 7838657 Spinal muscular atrophy (SMA) treatment via targeting of
0
‌
US Patent 7872017 Fused bicycloheterocycle substituted azabicyclic alkane derivatives
0
‌
US Patent 7902222 Biaryl substituted azabicyclic alkane derivatives
0
‌
US Patent 7919514 Thiadiazole compounds and methods of use
0
‌
US Patent 7973015 Induction of exon skipping in eukaryotic cells
0
‌
US Patent 8014953 RNA surveillance among curated proteins
0
‌
US Patent 8133724 Human androgen receptor alternative splice variants as biomarkers and therapeutic targets
0
‌
US Patent 8283116 Methods of screening for compounds for treating spinal muscular atrophy using SMN mRNA translation regulation
0
‌
US Patent 8437067 Electrochemical display element
0
‌
US Patent 8603457 Nonsense suppression and genetic codon alteration by targeted modification
0
‌
US Patent 8609662 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha. 7-nachr ligands for the treatment of CNS diseases
0
‌
US Patent 8609852 Thiazolyl mGluR5 antagonists and methods for their use
0
‌
US Patent 8633019 Methods for treating spinal muscular atrophy
0
‌
US Patent 8729263 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
0
‌
US Patent 8802642 Spinal muscular atrophy treatment via targeting SMN2 catalytic core
0
‌
US Patent 8853241 Biaryl substituted azabicyclic alkane derivatives
0
‌
US Patent 8933090 1-aza-bicyclo[3.3.1]nonanes
0
‌
US Patent 8940762 Methods for treating pain
0
‌
US Patent 8969346 Amino-pyridazine skeletal muscle modulators
0
‌
US Patent 9040712 Thiadiazole analogs thereof and methods for treating SMN-deficiency-related-conditions
0
‌
US Patent 9078823 Compositions and methods for gene silencing
0
‌
US Patent 9133123 Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
0
‌
US Patent 9163017 Anti-viral compounds
0
‌
US Patent 9243245 Means and methods for counteracting muscle disorders
0
‌
US Patent 9371336 Compounds for treating spinal muscular atrophy
0
‌
US Patent 9394539 Survival motor neuron gene (SMN2) mRNA constructs for post-transcription regulation
0
‌
US Patent 9399649 Compounds for treating spinal muscular atrophy
0
‌
US Patent 9447075 Pyridazine derivatives as EAAT2 activators
0
‌
US Patent 9464065 Compounds and methods for inducing chondrogenesis
0
‌
US Patent 9475811 1-aza-bicyclo[3.3.1]nonanes
0
‌
US Patent 9545404 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
0
‌
US Patent 9586955 Compounds for treating spinal muscular atrophy
0
‌
US Patent 9604965 Substituted pyridazines as skeletal muscle modulators
0
‌
US Patent 9617268 Compounds for treating spinal muscular atrophy
0
‌
US Patent 9714422 Reducing intron retention
0
‌
US Patent 9717750 Compositions and methods for modulation of SMN2 splicing in a subject
0
‌
US Patent 9730886 Amino-pyrimidine skeletal muscle modulators
0
‌
US Patent 9745577 Reducing intron retention
0
‌
US Patent 9879007 Compounds for treating spinal muscular atrophy
0
‌
US Patent 9895358 Combination therapies for treatment of spinal muscular atrophy
0
‌
US Patent 9914722 Compounds for treating spinal muscular atrophy
0
‌
US Patent 9956223 Screening method
0
‌
US Patent 9963699 Methods for modulating C9ORF72 expression
0
‌
US Patent 9982260 Identification of structurally similar small molecules that enhance therapeutic exon skipping
0
‌
US Patent 10006027 Methods for modulating Ataxin 2 expression
0
‌
US Patent 10053697 Programmable alternative splicing devices and uses thereof
0
‌
US Patent 10076519 Substituted pyridazines as skeletal muscle modulators
0
‌
US Patent 10093678 Azaspiro derivatives as TRPM8 antagonists
0
‌
US Patent 10112923 1,2,4-triazine-4-amine derivatives
0
‌
US Patent 10195196 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
0
‌
US Patent 10196639 Modulation of gene expression and screening for deregulated protein expression
0
‌
US Patent 10252984 Inhibiting G protein coupled receptor 6 kinase polypeptides
0
‌
US Patent 10358427 Modulators of indoleamine 2,3-dioxygenase
0
‌
US Patent 10377742 AMPK-activating heterocyclic compounds and methods for using the same
0
Patent Primary Examiner
‌
Susanna Moore
0
CPC Code
‌
C07D 451/14
0
‌
C07D 451/06
0
‌
C07D 519/00
0
‌
C07D 498/08
0

Find more entities like US Patent 11964971 Methods and compositions for modulating splicing

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo